Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Risk for severe weather this weekend. The best chance for rain and when storms move in the area
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Biomind Labs Inc.
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
September 14, 2023
From
Biomind Labs Inc.
Via
Business Wire
Tickers
BMNDF
Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression
April 26, 2022
From
Biomind Labs Inc.
Via
Business Wire
Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form
November 18, 2021
From
Biomind Labs Inc.
Via
Business Wire
Biomind Labs to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression
August 18, 2021
From
Biomind Labs Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.